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ever, in addition to this transcriptional regulation, it is
now clear that the protein products of these genes are
also controlled posttranslationally by phosphorylation,
protein-protein interactions, intracellular localization,
and by regulated degradation, events which are them-
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selves often controlled rhythmically (reviewed in [3–5]).
All of these levels of control appear to be crucial, if not
for progression of the clock cycle, then for introducingSummary
the proper kinetic parameters, which are critical for a
properly timed, circa 24-hr cycle.Background: Different types of regulation are utilized
In addition to the described transcriptional and post-to produce a robust circadian clock, including regulation
translational controls, it is also clear that circadianat the transcriptional, posttranscriptional, and transla-
clocks rely on posttranscriptional regulatory mecha-tional levels. A screen for rhythmic messages that may
nisms. The rhythmicity of clock gene mRNA levels, abe involved in such circadian control identified noctur-
hallmark of circadian systems, implies that the half-livesnin, a novel gene that displays high-amplitude circadian
of these messages must be tightly regulated. Evidenceexpression in the Xenopus laevis retina, with peak mRNA
from Arabidopsis, Drosophila, and mammals indicateslevels in the early night. Expression of nocturnin mRNA
that posttranscriptional regulatory mechanisms are im-is confined to the clock-containing photoreceptor cell
portant for maintaining proper control of circadian-rele-layer within the retina.
vant mRNA levels [6–10]. Although nothing is currentlyResults: In these studies, we show that nocturnin re-
known about the molecular nature of the posttranscrip-moves the poly(A) tail from a synthetic RNA substrate in
tional control, data from Drosophila suggest that thisa process known as deadenylation. Nocturnin nuclease
regulatory step is itself rhythmic [7].activity is magnesium dependent, as the addition of
A novel rhythmic gene, nocturnin, so called becauseEDTA or mutation of the residue predicted to bind mag-
its mRNA is transcribed at highest levels in the earlynesium disrupts deadenylation. Substrate preference
night, was identified in a differential display screen de-studies show that nocturnin is an exonuclease that spe-
signed to isolate rhythmic genes from Xenopus laeviscifically degrades the 3 poly(A) tail. While nocturnin is
retina [11, 12]. The retina of Xenopus contains an endog-rhythmically expressed in the cytoplasm of the retinal
enous circadian clock [13, 14] that regulates a numberphotoreceptor cells, the only other described vertebrate
of physiological and biochemical processes (revieweddeadenylase, PARN, is constitutively present in most
in [15]). The nocturnin gene exhibits high amplituderetinal cells, including the photoreceptors.
rhythms of mRNA expression in both cyclic light andConclusions: The distinct spatial and temporal expres-
constant conditions [12]. In the Xenopus retina, noctur-sion of nocturnin and PARN suggests that there may
nin mRNA is located exclusively in the rods and conesbe specific mRNA targets of each deadenylase. Since
of the photoreceptor cell layer [11]. These cells are thedeadenylation regulates mRNA decay and/or transla-
location of the circadian clock that drives the rhythmictional silencing, we propose that nocturnin deadenylates
release of melatonin [16, 17] and express Xenopus ho-clock-related transcripts in a novel mechanism for post-
mologs of known clock genes [18, 19].transcriptional regulation in the circadian clock or its
A mouse homolog of nocturnin (mNoc) has been iden-outputs.
tified that is highly conserved at the amino acid level
[20, 21]. However, in contrast to Xenopus, mNoc mRNA
Introduction is expressed widely in tissues of the mouse, including
liver, kidney, brain (including suprachiasmatic nucleus
Circadian clocks that control rhythmic behavioral, physi- [SCN] and pineal), lung, and heart in addition to the retina
ological, and biochemical processes are found in organ- [20, 21]. High-amplitude circadian mRNA expression of
isms from cyanobacteria to humans. Recently, examina- nocturnin has been observed in several of these tissues,
tion of the molecular mechanisms underlying these with peak levels in the early night [21–25]. Nocturnin
clocks in many of these species has revealed that the homologs have been cloned from human, cow, chicken,
general mechanism is conserved, even in cases in which and Drosophila, and sequence analysis shows possible
the specific genes are not (reviewed in [1, 2]). Although homologs in Arabidopsis [20, 21, 26].
the central core of the clock mechanism is comprised At the time it was discovered, database analyses indi-
of a negative feedback loop of transcription and transla- cated that nocturnin was a novel protein and was similar
tion, recent data have shown that many different levels in sequence only to the C terminus of the Ccr4p protein
of regulation are utilized in order to generate a robust in Saccharomyces cerevisiae [12], which was originally
circadian clock. For example, the Drosophila and verte- identified as a transcriptional coactivator [27]. Of the
brate clocks rely on both transcriptional activation and total 388 amino acids of Xenopus nocturnin, the last 291
repression of central clock genes (reviewed in [3]). How- align with the last third of Ccr4p, with 31% identity and
49% similarity at the amino acid level [12]. Recently, it
has been recognized that, by virtue of their common*Correspondence: cbg8b@virginia.edu
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domain, nocturnin and Ccr4p belong to a larger family A substrate for the deadenylase assays was gener-
ated from plasmid G52, a construct containing a 100of magnesium-dependent nucleases. While pairwise
comparisons show that the overall sequence conserva- nucleotide poly(A) tail cloned downstream of a portion of
the-globin 3UTR [40]. This construct can be linearizedtion is low, members of this family, which include pro-
teins such as DNase I, the DNA-repair apurinic/apyrimid- with a unique restriction enzyme, such that a runoff
transcript containing the poly(A) tail can be synthesizedinic (AP) endonuclease APE1, and the family of inositol
polyphosphate 5-phosphatases (IP5P), share pockets of from the SP6 promoter (Figure 1A) [40]. The mRNA was
labeled with [-32P]-UTP, producing a transcript withsimilar amino acid residues [26, 28–31]. The conserved
residues, including a highly conserved magnesium bind- radioactivity incorporated into the body of the message.
Recombinant GST-nocturnin protein was incubated withing domain, are important for catalysis. Furthermore,
fold analysis software predicts that nocturnin threads this transcript containing the poly(A) tail (G52 A), and
the resulting products were separated on denaturingwell with APE1, suggesting structural similarity [29].
Recently, the C-terminal region of Ccr4p that aligns polyacrylamide gels. Addition of nocturnin resulted in a
time-dependent change in size, consistent with com-with nocturnin and other proteins of the magnesium-
dependent nuclease family was shown to contain dead- plete removal of the poly(A) tail (Figure 1B, lanes 1–6).
The nocturnin deadenylase activity was compared toenylase function [32]. Deadenylation, the process of re-
moving the poly(A) tail, is the initial and rate-limiting that of the known metazoan deadenylase PARN [37, 39,
40] by using the same assay conditions. After a 30-minstep in mRNA turnover [33], and recent modeling data
suggest that the largest changes in mRNA half-life and incubation, recombinant HIS-PARN also converts the
poly(A) G52 substrate to a deadenylated form; how-life span are due to changes in the rate of deadenylation
[34]. Deadenylation also mediates translational silencing ever, PARN trims approximately 6–7 nucleotides beyond
the poly(A) tail into the body of the message (Figure 1C).in early vertebrate development [35]. Mutations in amino
acid residues of Ccr4p shown to be important for cataly- The substrate preference of nocturnin deadenylation
was examined by adding excess cold competitors tosis in other members of the magnesium-dependent
nuclease family disrupt the deadenylation function of the deadenylase reaction. While increasing amounts of
cold polyadenylic acid (poly(A)) compete with deadeny-Ccr4p [30, 36].
In vertebrates, the only well-characterized deadeny- lation of the G52 RNA substrate, the addition of cold
polydeoxyadenylic acid (poly(dA)) has no affect on poly(A)lase to date is PARN, a poly(A)-specific exoribonuclease
first isolated from calf thymus [37]. In Xenopus oocytes, tail removal (Figure 2A). If nocturnin is degrading
poly(dA), it does so with much lower affinity, such thatPARN is responsible for the deadenylation of maternal
mRNAs during meiotic maturation [38–40]. PARN is also poly(dA) does not compete with the deadenylation of
the G52 substrate. Therefore, it is unlikely that single-the major deadenylase present in an mRNA decay sys-
tem derived from HeLa cell extracts [41]. Recent data stranded DNA is a substrate of nocturnin.
RNA specificity of nocturnin was investigated by usingsuggest that the human homolog of Ccr4p (hCCR4) may
also be a deadenylase, although its activity is not as additional substrates, all of which were linearized and
synthesized to create a radiolabeled transcript. We firstrobust as yeast Ccr4p in vitro and it does not comple-
ment any of the phenotypes of a yeast CCR4 deletion compared nocturnin’s ability to degrade transcripts con-
taining either a G(30) tract or an A(30) tract at the 3 end.in vivo [30].
In this paper, we demonstrate that nocturnin is a dead- Upon addition of nocturnin, a substrate called ML43(G30),
which contains a portion of the vector pBS followed byenylase belonging to the magnesium-dependent family
of nucleases. In addition, we show that nocturnin protein a 30 nucleotide poly(G) tract at the 3 end [43], was not
degraded (Figure 2B, compare lanes 3 and 4). However,is expressed with a circadian profile in the retinal photo-
receptors of Xenopus laevis. In contrast, PARN is ex- nocturnin removes the entire 30 nucleotide poly(A) tail at
the 3 end of another synthetic substrate called L3(A30),pressed throughout the retina at constitutive levels, sug-
gesting that these two deadenylases act on different indicating its preference for poly(A) RNA (Figure 2B,
compare lanes 1 and 2) . Furthermore, the RNA se-subsets of mRNAs. The circadian expression and local-
ization within clock-containing cells suggests that noc- quence upstream of the poly(A) tail does not affect noc-
turnin’s precise specificity for poly(A) degradation inturnin deadenylates circadian-relevant target mRNAs.
these in vitro assays. For instance, nocturnin degradesTo our knowledge, nocturnin is the first protein impli-
the 3 poly(A)100 tail of the HP1 synthetic substrate thatcated in posttranscriptional regulation of circadian
contains a poly(C)24 homopolymer tract upstream ofclock-related transcripts.
the poly(A) tail [38] (Figure 2B, lane 6). In other substrates
tested, nocturnin also degrades the 3 poly(A) tail only,
Results again stopping exactly at the junction between the ho-
mopolymeric poly(A) RNA and the upstream heteropo-
Nocturnin Is a Poly(A)-Specific Exonuclease lymeric RNA sequence (G52 A, Figure 1B; L3(A30),
Nocturnin belongs to a family of nucleases that includes Figure 2B). Taken together, these data confirm that noc-
apurinic/apyrimidinic (AP) base excision repair endonu- turnin acts as an RNA-specific nuclease with precise
cleases and inositol polyphosphate 5-phosphatases specificity for degradation of the poly(A) tail.
[28, 29]. Since nocturnin contains a region similar in Substrate preference of nocturnin deadenylation was
sequence to the carboxy terminus of the previously iden- further investigated by using a modified version of the
tified deadenylase Ccr4p [30, 32, 36, 42], we tested noc- G52 transcript, denoted G52(A)100(N)31. This construct
was generated by linearizing the G52 construct 31 nucle-turnin for deadenylase function.
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Figure 1. Nocturnin Exhibits Deadenylase Activity In Vitro in a Magnesium-Dependent Manner
(A) A diagram of G52 DNA shows resulting constructs G52 A (189 nt) and G52 A(100)N(31) (217 nt) when linearized with BamHI and HindIII
restriction enzymes, respectively. After restriction digests, radiolabeled runoff transcripts are generated from the SP6 promoter in the presence
of [-32P]-UTP. G52 A and G52 A(100)N(31) contain a 100 nucleotide poly(A) tail followed by either 3 or 31 non-adenylate sequence, respectively.
(B) Nocturnin deadenylates a synthetic mRNA substrate in a time-dependent, EDTA-sensitive manner. Purified nocturnin protein (GST-noc, 1
g) was incubated with radiolabeled poly(A) G52 mRNA, and deadenylation was measured at time points up to 30 min (lanes 1–6). A decrease
of activity was observed with the addition of EDTA (lane 7). Arrows indicate poly(A) and poly(A) sizes, and estimated transcript size is
based on comparison with a marker of 189 nt and 75 nt (M, lane 8) and an RNA ladder (not shown).
(C) HIS-PARN (0.08 g) was tested by using the same assay conditions and serves as a positive control.
(D) Deadenylase activity was abolished when a point mutation was generated in the putative magnesium binding domain of nocturnin (E152A).
Equal amounts of WT and E152A protein (1 g) were added for direct comparison.
otides after the poly(A) tail, resulting in a transcript con- that nocturnin shares a similar magnesium-dependent
catalytic mechanism with the APE1 family of nucleases.taining a non-adenylate vector sequence at the 3 end
(Figure 1A). Deadenylation was assessed on this sub-
strate as before by using identical reaction conditions. Localization of Endogenous Nocturnin
within the RetinaWhereas nocturnin degrades the G52 A transcript con-
taining only three non-adenylate residues after the po- The temporal expression profile of retinal nocturnin pro-
tein was examined by using an affinity-purified antibodyly(A) tail, the G52(A)100(N)31 message is not degraded
(Figure 2B, compare lane 8 and 9). Since nocturnin trims raised against nocturnin amino acids 51–69 (anti-noc
51–69). This antibody specifically recognizes the dena-the poly(A) tail only when it is found at the 3 end of a
transcript, we therefore conclude that nocturnin is a tured form of nocturnin on Western blots, as we observe
a single band of the predicted size from COS7 and bac-poly(A)-specific 3 exonuclease.
Alignment of nocturnin with members of the magne- terial cell lysates expressing full-length and tagged ver-
sions of nocturnin (data not shown). To investigate noc-sium-dependent family of nucleases shows several con-
served domains, including a magnesium binding domain turnin in the retina, we collected retinal extracts every 4
hr over one 24-hr day. Given that nocturnin was originally[26, 29, 44, 45]. When EDTA, a divalent cation chelator,
was added to the deadenylation reaction, nocturnin no identified as a gene with rhythmic mRNA expression in
the Xenopus laevis retina [12], we hypothesized thatlonger digested the poly(A) tail of the G52 transcript
(Figure 1B, compare lanes 6 and 7). To further test the nocturnin protein would also be rhythmic in abundance.
As expected, nocturnin is expressed at low levels duringrequirement of magnesium binding for nocturnin activ-
ity, a point mutation was generated in the putative mag- the day, increases throughout the night, and reaches
maximum levels in the late night and early morning (Fig-nesium binding residue. In APE1, a point mutation in the
analogous residue nearly abolishes APE1 endonuclease ure 3A). The predicted size of nocturnin based on its
amino acid sequence is 43 kDa, which corresponds toactivity [45, 46]. The magnesium binding mutant gener-
ated by changing the glutamate to alanine (E152A) ren- the lower molecular weight band on this blot. A larger
band of approximately 62 kDa is also rhythmic in theders GST-nocturnin unable to carry out its deadenylase
activity (Figure 1D, compare lanes 1 and 2), indicating same phase as the more prominent lower band, and it
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Figure 2. Nocturnin Is an Exonuclease that Prefers Poly(A) as a Substrate
(A) The addition of poly(A), but not poly(dA), competed with nocturnin deadenylation of the G52 A substrate. Nonradiolabeled competitors
were added in increasing amounts (0.001 g, 0.01 g, 0.1 g, and 0.5 g from left to right) to the deadenylase reaction containing 0.05 g
of a 50% slurry of GST-nocturnin bound to glutathione beads.
(B) Left panel: the 30 nucleotide poly(A) tail at the end of the 84 nucleotide L3(A30) RNA substrate is removed upon addition of nocturnin
(compare lanes 1 and 2), while a 30 nucleotide tract of poly(G) at the end of the 73 nucleotide ML43(G30) substrate is not removed by nocturnin
(lanes 3 and 4). The 173 nucleotide HP1 substrate, containing a poly(C)24 tract followed by a poly(A)100 tail and four non-A residues at the
most distal end, is deadenylated by nocturnin to create a 69 nucleotide transcript lacking the poly(A) tail (lanes 5 and 6). Each reaction contains
0.05 g of a 50% slurry of GST-nocturnin bound to glutathione beads. Sizes of the RNA substrates are based on comparison of predicted
size to RNA markers. Right panel: deadenylation occurs only when the poly(A) tail is located at the end of the synthetic transcript. G52
substrate with 31 nucleotides after the poly(A) tail (G52 A(100)N(31), denoted A in this figure) and G52 A substrate were incubated with or
without 0.4 g of a 50% slurry of GST-nocturnin bound to glutathione beads, as indicated.
may be a posttranslationally modified version of noctur- To examine the localization of endogenous nocturnin
protein in the retina, we used a second antibody gener-nin, since its immunoreactivity can be depleted when
the antibody is first incubated with the peptide antigen ated against the first 20 amino acids of nocturnin (anti-
noc 1–20). This affinity-purified antibody recognizes the(data not shown). This blot was stripped and reprobed
with an antibody that recognizes actin to control for native form of nocturnin both in immunoprecipitation
(data not shown) and immunohistochemistry. Immuno-equal protein loading (lower panel, Figure 3A).
Figure 3. Comparison of Nocturnin and PARN Protein Expression in the Retina
Western blot analysis was performed on Xenopus laevis retinal proteins collected at 4-hr intervals throughout the 24-hr day/night cycle.
(A) Using an affinity-purified antibody generated against nocturnin amino acids 51–69, we show that nocturnin is expressed with circadian
rhythmicity in the retina, with peak levels at mid- to late night.
(B) PARN protein is expressed constitutively in the retina, with equivalent expression levels throughout the 24-hr cycle.
After nocturnin or PARN protein was examined, the blots were stripped and reprobed with an antibody that recognizes actin to control for
equal loading (bottom panel). ZT refers to zeitgeber time; ZT 0 is the onset of light, and ZT 12 is lights-off in a 12 hr light/12 hr dark cycle.
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Figure 4. Nocturnin Is Expressed in the Cytoplasm of Rod and Cone Photoreceptor Cells
(A) Eyecups from Xenopus laevis collected at ZT 8 and ZT 22 were sectioned and stained with anti-noc 1–20 antibody. For each time point,
nocturnin staining is shown in the first photo, and a merged image of nocturnin staining (red) and nuclei stained with Hoescht dye (blue) is
shown in the second photo. Nocturnin staining is photoreceptor specific and is higher at ZT 22 than at ZT 8. Exposure times are the same
for all sections for comparison. Faint fluorescence in the inner retina is not consistently seen and may be due to long exposure time. PR,
photoreceptor cell body; OPL, outer plexiform layer; INL, inner nuclear layer.
(B) A slide incubated without primary antibody serves as a negative control.
staining of sectioned retinas with this antibody shows change in PARN staining from retinas collected at differ-
ent times of the day (compare ZT 8, 12, and 22 staining,nocturnin staining in the rods and cones (Figure 4A).
Nocturnin protein in the photoreceptor cells is consis- Figure 5), and the nonrhythmic expression of PARN was
confirmed by Western blotting of retinal extracts col-tent with the mRNA localization [11] and the identifica-
tion of a novel element named PCE II in the promoter lected over 1 day (Figure 3B). Much longer exposure
times are required to visualize nocturnin by Westernof nocturnin that targets its photoreceptor-specific ex-
pression [47]. Furthermore, nocturnin is located in the blotting and immunohistochemistry, suggesting that
PARN is present at higher levels than nocturnin. Thecytoplasm of photoreceptor cells (Figure 4A). This cyto-
solic localization has been confirmed in COS7 cells and overlapping expression of nocturnin and PARN in the
photoreceptor cells indicates that at least two deadeny-the Xenopus laevis retina by overexpressing nocturnin-
GFP fusion proteins (data not shown). Consistent with lases are functioning in these cells. The rhythmic expres-
sion of nocturnin suggests that it deadenylates in a cir-results from Western blotting (Figure 3A), nocturnin im-
munostaining is at high levels during the night (ZT 22) cadian manner.
and is barely detectable during the day (ZT 8) (Figure 4A).
The rhythmic abundance of nocturnin protein predicts Discussion
that its deadenylase activity would be confined to a time
period during the mid- to late night. We investigated In this paper, we demonstrate that recombinant noctur-
nin is a poly(A)-specific 3 exonuclease and is thereforewhether nocturnin is the only deadenylase in the retina,
or if another poly(A)-specific nuclease acts in combina- a newly characterized deadenylase. As predicted by
sequence analysis, nocturnin belongs to the APE1 su-tion with nocturnin, with perhaps each deadenylating a
unique subset of messages. A comparison of the ex- perfamily of nucleases that share a similar catalytic
mechanism. We show functionally that nocturnin is apression profiles of nocturnin and PARN was undertaken
in the retina. The localization of PARN within the retina member of this family, as mutation of the putative mag-
nesium binding residue renders it catalytically inactive.was examined by immunohistochemistry on sectioned
retinas by using an antibody previously generated Although nocturnin and Ccr4p share a similar catalytic
mechanism, comparison of their deadenylase activitiesagainst PARN [39]. In contrast to the photoreceptor-
specific expression of nocturnin, we observed PARN in revealed several interesting differences. While Ccr4p
degrades both poly(A) and single-stranded DNA [30], itseveral different cell types, including the photoreceptor
cells and cells of the inner retina (Figure 5). As observed is unlikely that single-stranded DNA is a substrate of
nocturnin. The addition of excess single-stranded DNAin mammalian cells and Xenopus oocytes [39], PARN is
distributed between both the cytoplasm and nucleus (poly (dA)) to the deadenylation reactions had no effect
on nocturnin’s ability to deadenylate the G52 substrateof the retinal cells (Figure 5). There was no consistent
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Figure 5. PARN Deadenylase Is Expressed at Constitutive Levels in Many Cells of the Retina
Immunostaining of retinal sections from ZT 8, 12, and 22 with PARN antibody shows that PARN is located in photoreceptor cells and many
cells of the inner retina. Merged images of PARN staining (red) and nuclei stained with Hoescht dye (blue) are shown for each image. Brackets
denote the photoreceptor cell layer (PR) and inner nuclear layer (INL), as indicated.
(Figure 2B). Another striking difference between these binding partner may assist in regulation of deadenylase
activity and/or recognition of the substrate in vivo. Fur-two enzymes includes their degradation of the sub-
thermore, the synthetic G52 substrate used in thesestrate. In contrast to Ccr4p [30], nocturnin appears to
assays is most likely not the physiological substrate offunction in a highly processive manner, since no degra-
nocturnin, and factors that affect mRNA stability, suchdation intermediates are visible. Interestingly, recombi-
as poly(A) binding protein (PABP), are not present. Char-nant PARN deadenylase activity is also processive, and
acterization of the endogenous nocturnin and associ-the same characteristics described for PARN processi-
ated proteins may provide insight into its activity in vivo,vity apply to nocturnin: no partially degraded species
including the identity of relevant substrate mRNAs.were visible after nocturnin was added to the mRNA
Since different mRNAs exhibit a wide range of half-substrate, and the unreacted substrate containing a po-
lives, often changing in response to stimuli, it seemsly(A) tail was present at the same time as the fully dead-
likely that deadenylases should demonstrate specificityenylated products (Figures 1 and 2) [48].
in their recognition of target messages. However, little isAlthough deadenylation of mRNAs is the rate-limiting
known about the specific mRNA substrates of individualstep in triggering mRNA turnover [34] and can also regu-
deadenylases or how particular target mRNAs are rec-late translation [33, 49], only a few deadenylases have
ognized. One target mRNA of the Ccr4p/Pop2p dead-previously been identified. In vertebrates, PARN is the
enylation complex was recently shown to be the COX17only well-characterized deadenylase [33], though the
mRNA, which is regulated through its mRNA bindingvertebrate homolog of Ccr4p may function in poly(A) tail
protein Puf3p [51] and undergoes much slower rates ofremoval [30]. In yeast, both the Ccr4p complex (Ccr4p
deadenylation in ccr4, pop2, and ccr4/pan2 mu-associates with another protein called Pop2p, which
tants [36]. In vertebrates, the deadenylation and subse-
may also have deadenylase activity [42]) and the Pan2p/
quent translational silencing of mRNAs by PARN during
Pan3p complex are thought to function in deadenylation, early development occurs by default [38, 39]. While se-
as removal of both deadenylase complexes is necessary quence-specific deadenylation of other messages also
to disrupt poly(A) trimming in vivo [32]. While the Pan2p/ occurs throughout this time, the deadenylase(s) tar-
Pan3p complex cleaves the poly(A) tail of newly synthe- geting these mRNAs is unknown.
sized messages, the Ccr4p/Pop2p complex is thought Comparison of the spatial and temporal expression
to be involved in deadenylation-dependent mRNA decay profiles of nocturnin and PARN in the retina suggests
[32, 50]. that each deadenylase has a distinct function. While
Like the Ccr4p/Pop2p and Pan2p/Pan3p deadenyla- PARN is found in many retinal cells, nocturnin is confined
tion complexes found in yeast, nocturnin may also asso- to the circadian clock-containing photoreceptor cells
ciate with other proteins in a poly(A)-specific degrada- (Figures 4 and 5). Even within the photoreceptor cells,
tion complex. Gel filtration analysis of retinal extracts both PARN and nocturnin are present in the cytosol.
predicts that nocturnin is found in a complex of proteins In addition, PARN is expressed at constitutive levels
(data not shown), and nocturnin may interact with other throughout the entire 24-hr cycle, while nocturnin is ex-
proteins through its leucine zipper-like motif [12]. Be- pressed in a circadian manner, with highest levels at
cause a potential binding partner of nocturnin is absent night (Figures 3–5). This predicts that the in vivo targets
in our in vitro assays, we predict that poly(A) tail removal of nocturnin deadenylase activity are messages related
to rhythmic processes within these cells.by nocturnin may not entirely reflect its in vivo activity. A
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Posttranscriptional regulation, such as deadenylation, The generation of daily fluctuating levels of mRNAs
is a central feature of circadian clocks. The rhythmicityin the circadian clock is not unprecedented, as there
are several reports of circadian changes in poly(A) tail of some mRNAs may be the result of rhythmic changes
in stability rather than (or in addition to) rhythmiclength or mRNA stability. One example involves vaso-
pressin, a neuropeptide that plays a role in regulating changes in transcription [65, 66]. For example, in Arabi-
dopsis, the nitrate reductase gene oscillates in steady-circadian behavioral rhythmicity ([52]; reviewed in [53,
54]). Within the SCN, the site of the master pacemaker state levels of abundance over a 24-hr day, as measured
by Northern blot. However, this rhythmicity must be duein mammals [55, 56], vasopressin mRNA fluctuates in a
circadian manner with peak levels during midday [57– to changes in the mRNA stability, since nuclear run-
on assays show that the message is transcribed at a59]. In addition, the size of the poly(A) tail of the vaso-
pressin message changes over the 24-hr day, with the constant rate [10].
The work presented in this paper provides the firstlarger species present during the day and both the larger
and smaller forms found at night [8]. This change in inroad into the mechanism regulating posttranscrip-
tional control of the clock and/or clock processes andpoly(A) tail size is under the control of the circadian clock
and is a specific feature of the SCN, as a vasopressin will most likely be applicable to clocks across species
since homologs of nocturnin have been identified inmessage only exists with a fully adenylated poly(A) tail in
other brain regions, including the paraventricular nuclei mammals, Drosophila, and Arabidopsis. In addition to
rhythmic expression of Xenopus nocturnin within theand the supraoptic nuclei [6, 8]. The function of this
circadian-regulated change in poly(A) tail length is un- clock-containing retinal photoreceptor cells, expression
data from studies on mNoc also support the idea thatknown, although it may be involved in controlling stabil-
ity or translation of this message. Overall, these data nocturnin may be involved in some aspect of circadian
clock regulation. For instance, mNoc is rhythmically ex-suggest that deadenylation of the vasopressin message
is occurring in a circadian-controlled manner and may pressed in several tissues of the mouse that contain a
circadian clock [67–70], including liver, kidney, and heartbe regulated by a rhythmic deadenylase.
In both Drosophila and mice, there is evidence that [21, 23–25], suggesting that nocturnin functions in more
than just the day/night variation that occurs within thethe period gene (dper and mPer1, respectively) is con-
trolled in a posttranscriptional manner. In Drosophila, retinal photoreceptor cells in which it was originally iden-
tified. These data, in conjunction with recent microarraydper mRNA is expressed in a rhythmic manner, with
highest mRNA levels around the light/dark transition data indicating that few genes besides the core circa-
dian clock genes are expressed with rhythmic profiles[60]. Nuclear run-on assays have shown that dper is
transcribed rhythmically, and that during the daily rise in in both heart and liver [24], suggest that rhythmicity of
nocturnin may be important for maintaining a functionaldper message levels there is a lag between transcription
rate and accumulation of the mRNA [7]. In contrast, circadian clock in these peripheral tissues. The exis-
tence of posttranscriptional regulation in clock mecha-during the decline of this message, the profiles of the
transcription rate and the mRNA levels overlap, as the nisms of several different species suggests that proteins
like nocturnin that function in mRNA regulation may playhalf-life of dper mRNA has decreased 2- to 4-fold, indi-
cating that there must be rhythmic degradation [7]. Fur- a role in this process.
ther evidence for posttranscriptional regulation of dper
comes from experiments using transgenic flies con- Conclusions
taining a promoterless form of the gene. Although this These studies show that nocturnin functions as a poly(A)
form of dper is transcribed constitutively, the mRNA tail-specific 3exonuclease in a process called deadeny-
levels cycle with about a 2- to 3-fold amplitude [7, 61]. lation. Because it is expressed rhythmically in the clock-
These changes in mRNA half-life demonstrate the ne- containing cells of the Xenopus laevis retina, we propose
cessity for posttranscriptional modifications at some that nocturnin deadenylates in a circadian manner, act-
point during the mRNA lifetime that alter the stability of ing on a subset of circadian-related target mRNAs.
the message.
In the mammalian SCN, the mPer1 gene is transiently Experimental Procedures
induced by a brief (15–30 min) light pulse during early
or late night [62–64], and mPer1 induction is thought to Protein Purification
be a critical part of the light entrainment pathway [63]. GST-nocturnin
The Xenopus nocturnin cDNA was cloned into the EcoRI site ofRecent work suggests that the decline of mPer1 mRNA
pGEX4T-1 (Amersham Biosciences). The pGST-nocturnin DNA wasafter light induction is also controlled posttranscription-
transformed into E. coli BL21 (DE3) cells (Stratagene), and the bacte-ally. Using a transgenic mouse expressing luciferase
ria were grown at 37C in LB medium supplemented with 80 g/ml
driven by the mPer1 promoter (mPer1-luc), the expres- ampicillin until A600 	 0.5. The cells were induced with 0.01 mM
sion profiles of endogenous mPer1 and the transgenic isopropyl--D-thiogalactopyranoside (IPTG) (Gold Biotech) and
mPer1-luc construct in the SCN were compared follow- were harvested 3 hr later. Cells were resuspended by vortexing in
lysis buffer (20 mM HEPES-NaOH [pH 7.5], 1 mM EDTA, 150 mMing light exposure [9]. Although the transgenic mPer1-
NaCl, 0.5 mM PMSF), and lysozyme (Sigma) was added to a finalluc gene was induced with similar kinetics to the endog-
concentration of 0.015 mg/ml. The cells were lysed by sonication,enous mPer1 gene, the luc mRNA had a much slower
Triton X-100 was added to a final concentration of 1% (v/v), andrate of decay and a longer half-life when compared to
the lysate was incubated with mixing at 4C for 30 min. Cell debris
the endogenous mPer1 message; this finding suggests was pelleted by centrifugation at 20,000 
 g for 30 min, and the
specific posttranscriptional regulation of mPer1 mes- soluble cell lysate was added to 2 ml glutathione sepharose slurry
(Amersham Pharmacia) that was equilibrated in lysis buffer  0.5%sage stability via its 3 UTR [9].
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(v/v) Triton X-100. After a 30-min incubation at room temperature, primary antibody (1:15 anti-nocturnin 1–20 or 1:1000 PARN [39])
overnight at 4C. Sections were washed three times with wash solu-the sepharose bound to GST-nocturnin was washed four times with
lysis buffer  0.5% (v/v) Triton X-100 and was stored at 4C in tion (TBS [50 mM Tris base, 150 mM NaCl]  0.3% [v/v] Triton
X-100), then incubated with a 1:1500 dilution of donkey anti-rabbitHEPES dialysis buffer (50 mM HEPES-NaOH [pH 7.6], 150 mM NaCl,
2 mM MgCl2, 20% [v/v] glycerol, 0.1% [v/v] NP-40) [30]. Proteins conjugated-Cy3 antibody (Jackson Immunoresearch) for 1 hr. Sec-
tions were washed twice, stained for 15 min in 1 g/ml Hoescht Nawere eluted from the sepharose with glutathione (Sigma), and the
Bradford protein assay was used to quantitate the amount of purified 33342 (Sigma), then washed two more times before coverslips were
added with Fluoromount (Electron Microscopy Sciences). All anti-GST-nocturnin protein (Bio-Rad Protein Assay). Eluted protein was
dialyzed into HEPES dialysis buffer by using Slide-A-Lyzer Dialysis bodies were diluted in CBT blocking solution. Images were obtained
with an Olympus IX70 inverted fluorescence microscope.Cassettes (Pierce).
HIS-PARN
HIS-PARN [39] was expressed in E. coli BL21 (DE3) cells by growing Immunoblotting
cells in LB medium supplemented with 30 g/ml kanamycin at 37C. Retinas were dissected from adult male Xenopus laevis (Nasco) and
Once A600 	 0.5, the cells were induced with 0.1 mM IPTG and were were cultured in 80% defined balanced salts and amino acids [13]
grown for five more hours at 30C. The cells were pelleted, and the and 20% Wolf and Quimby amphibian tissue culture medium
HIS-PARN protein was purified by using the HIS purification kit (GIBCO-BRL) until the selected time point. Retinas were homoge-
following the manufacturer’s protocol for purification under native nized and pelleted in PBS, resuspended in buffer containing 20 mM
conditions (Novagen). The purified protein was dialyzed against 20 Na2HPO4-NaH2PO4 phosphate buffer (pH 7.9), 150 mM KCl, 0.625%
mM Tris-HCl (pH 8.0), and the protein concentration was determined (v/v) Igepal CA-630 (Sigma), 0.1 mM EDTA, 0.1 mM EGTA, 1:100
by using the BioRad DC Protein Assay (Bio-Rad Laboratories). protease inhibitor cocktail for mammalian extracts (Sigma), and 1
mM DTT, incubated on ice for 15 min, then sonicated. The superna-
Deadenylase Assays tant was removed after centrifugation at 10,000
 g, and the concen-
G52 substrates containing a 100 nucleotide poly(A) tail or 31 nonade- tration of the retinal extract was measured by using the BioRad DC
nylate residues distal to the poly(A) tail were generated by linearizing Protein Assay.
G52 plasmid DNA with BamHI or HindIII, respectively (Figure 1A). Extracts were separated by using 10%–12% SDS-PAGE, then
HP1, L3(A30), and ML43(G30) substrates were generated by first transferred to PVDF membrane (BioRad). After blocking overnight
linearizing with BamHI, NsiI, and ApaI restriction enzymes, respec- in Blotto (0.025% [w/v] powdered milk, 0.5
 TBS, 0.05% [v/v]
tively. Radiolabeled RNA substrates were synthesized by transcrib- Tween), the blot was incubated for 1 hr with primary antibody diluted
ing linearized DNA constructs with SP6 polymerase (GIBCO-BRL) in Blotto. Antibodies were used at the following concentrations:
(G52 and HP1) or T3 polymerase (Stratagene) (L3(A30), ML43(G30)) 1:500 anti-nocturnin 51–69, 1:1500 anti-PARN, or 1:3000 anti-actin
in the presence of [-32P]-UTP (800 Ci/mmol) and 625 M of a 5 (Sigma). Blots were washed with TBS-Tween (0.1% [v/v] Tween-
GpppG cap analog (Amersham Pharmacia Biotech). Resulting RNA 20 [Sigma]), then incubated with a 1:4000 dilution of anti-rabbit
products were separated on 6% polyacrylamide/7 M urea gels, then horseradish peroxidase-conjugated secondary antibody (Chemi-
excised and eluted in TNES buffer (0.1 M Tris-HCl [pH 7.5], 0.3 M con). After washing with TBS-Tween, blots were developed with
NaCl, 0.01 M EDTA, 2% [w/v] SDS) overnight at room temperature Chemiluminescence Blotting Substrate (Boehringer Mannheim). In
[40]. Purified RNA was incubated with GST-nocturnin purified pro- cases in which blots were stripped, the Reblot Western Blot Recy-
tein (0.01–1 g/reaction) in reaction buffer (5 mM HEPES [pH 7.5], cling kit was used according to the manufacturer’s instructions
2 mM MgCl2, 0.5 mM DTT, 10% [v/v] glycerol, 0.2 mg/ml BSA, 0.02% (Chemicon). For immunodepletion, anti-nocturnin 51–69 antibody
[v/v] NP-40, 0.3% [w/v] spermidine) for 30 min (unless otherwise was incubated for 4 hr at room temperature with 1g/ml of a peptide
noted) at 37C in the presence of 5 U RNase Block (Stratagene). corresponding to nocturnin amino acids 51–69.
Poly(A) (Roche) and poly(dA) (Sigma) competitors were acid hy-
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